Literature DB >> 25476840

[Visualization of local cortical defects in Charcot foot using microcomputed tomography].

S Senck1, B Plank, J Kastner, F Ramadani, K Trieb, S G Hofstaetter.   

Abstract

BACKGROUND: In the pathogenesis of diabetic neuropathic osteoarthropathy (Charcot's foot) fractures cause chronic destruction of soft tissue and bone structure. To improve an early diagnosis of Charcot foot, modern diagnostic imaging is mainly based on magnetic resonance imaging (MRI), for example in relation to the detection of cortical bone fractures.
OBJECTIVES: In this study we investigated the cortical microstructure in cases of Charcot foot with respect to fractures and porosity in order to visualize local cortical defects. This may substantiate recent efforts in a reclassification based on MRI.
MATERIAL AND METHODS: Using microcomputed tomography (microCT) we investigated bone parameters, such as cortical thickness and porosity in order to quantify the local metatarsal microstructure in cases of Charcot foot.
RESULTS: All bone samples showed a high degree of cortical porosity including pores that perforated the cortical bone. The data suggest that areas with reduced cortical thickness coincide with large cortical pores that may serve as initial points for fractures. Whether the detected microfractures are physiological or artefacts of preparation could not be determined.
CONCLUSION: By means of microCT we were able to visualize and quantify the extent of cortical porosity for the first time in high resolution. The data suggest that both cortical fractures and cortical porosity play an important role in the pathogenesis in cases of Charcot foot.

Entities:  

Mesh:

Year:  2015        PMID: 25476840     DOI: 10.1007/s00132-014-3053-0

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  16 in total

1.  Recent progress in bone imaging for osteoporosis research.

Authors:  Masako Ito
Journal:  J Bone Miner Metab       Date:  2011-02-08       Impact factor: 2.626

2.  Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial.

Authors:  E B Jude; P L Selby; J Burgess; P Lilleystone; E B Mawer; S R Page; M Donohoe; A V Foster; M E Edmonds; A J Boulton
Journal:  Diabetologia       Date:  2001-11       Impact factor: 10.122

3.  Blood flow in the diabetic neuropathic foot.

Authors:  M E Edmonds; V C Roberts; P J Watkins
Journal:  Diabetologia       Date:  1982-01       Impact factor: 10.122

4.  Bone structure and turnover in type 2 diabetes mellitus.

Authors:  A Shu; M T Yin; E Stein; S Cremers; E Dworakowski; R Ives; M R Rubin
Journal:  Osteoporos Int       Date:  2011-03-19       Impact factor: 4.507

5.  Micro-CT finite element model and experimental validation of trabecular bone damage and fracture.

Authors:  Ridha Hambli
Journal:  Bone       Date:  2013-07-10       Impact factor: 4.398

6.  Changes in intracortical microporosities induced by pharmaceutical treatment of osteoporosis as detected by high resolution micro-CT.

Authors:  Steven M Tommasini; Andrea Trinward; Alvin S Acerbo; Francesco De Carlo; Lisa M Miller; Stefan Judex
Journal:  Bone       Date:  2011-12-28       Impact factor: 4.398

7.  The Charcot foot: historical perspective 1827-2003.

Authors:  Lee J Sanders
Journal:  Diabetes Metab Res Rev       Date:  2004 May-Jun       Impact factor: 4.876

8.  Current challenges in imaging of the diabetic foot.

Authors:  S Eser Sanverdi; Bilge F Ergen; Ali Oznur
Journal:  Diabet Foot Ankle       Date:  2012-10-01

Review 9.  High-resolution computed tomography for clinical imaging of bone microarchitecture.

Authors:  Andrew J Burghardt; Thomas M Link; Sharmila Majumdar
Journal:  Clin Orthop Relat Res       Date:  2011-08       Impact factor: 4.176

10.  Age- and gender-related differences in the geometric properties and biomechanical significance of intracortical porosity in the distal radius and tibia.

Authors:  Andrew J Burghardt; Galateia J Kazakia; Sweta Ramachandran; Thomas M Link; Sharmila Majumdar
Journal:  J Bone Miner Res       Date:  2010-05       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.